Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 April 2007

Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif

  • Myoung-Ae Kim1,
  • Hyun-Ju Kim,
  • Alexandra L Brown,
  • Min-Young Lee,
  • Yoe-Sik Bae,
  • Joo-In Park,
  • Jong-Young Kwak,
  • Jay H Chung &
  • …
  • Jeanho Yun 

Experimental & Molecular Medicine volume 39, pages 205–212 (2007)Cite this article

  • 2220 Accesses

  • 50 Citations

  • Metrics details

Abstract

Checkpoint kinase 1 (Chk1) and Chk2 are effector kinases in the cellular DNA damage response and impairment of their function is closely related to tumorigenesis. Previous studies revealed several substrate proteins of Chk1 and Chk2, but identification of additional targets is still important in order to understand their tumor suppressor functions. In this study, we screened novel substrates for Chk1 and Chk2 using substrate target motifs determined previously by an oriented peptide library approach. The potential candidates were selected by genome-wide peptide database searches and were examined by in vitro kinase assays. ST5, HDAC5, PGC-1α, PP2A PR130, FANCG, GATA3, cyclin G, Rad51D and MAD1α were newly identified as in vitro substrates for Chk1 and/or Chk2. Among these, HDAC5 and PGC-1α were further analyzed to substantiate the screening results. Immunoprecipitation kinase assay of full-length proteins and site-directed mutagenesis analysis of the target motifs demonstrated that HDAC5 and PGC-1α were specific targets for Chk1 and/or Chk2 at least in vitro.

Similar content being viewed by others

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

Article Open access 23 August 2022

PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer

Article Open access 20 January 2024

DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma

Article Open access 03 November 2023

Article PDF

Author information

Authors and Affiliations

  1. Medical Research Center for Cancer Molecular Therapy, Korea

    Myoung-Ae Kim

Authors
  1. Myoung-Ae Kim
    View author publications

    Search author on:PubMed Google Scholar

  2. Hyun-Ju Kim
    View author publications

    Search author on:PubMed Google Scholar

  3. Alexandra L Brown
    View author publications

    Search author on:PubMed Google Scholar

  4. Min-Young Lee
    View author publications

    Search author on:PubMed Google Scholar

  5. Yoe-Sik Bae
    View author publications

    Search author on:PubMed Google Scholar

  6. Joo-In Park
    View author publications

    Search author on:PubMed Google Scholar

  7. Jong-Young Kwak
    View author publications

    Search author on:PubMed Google Scholar

  8. Jay H Chung
    View author publications

    Search author on:PubMed Google Scholar

  9. Jeanho Yun
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Kim, MA., Kim, HJ., Brown, A. et al. Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif. Exp Mol Med 39, 205–212 (2007). https://doi.org/10.1038/emm.2007.23

Download citation

  • Published: 01 April 2007

  • Issue date: 01 April 2007

  • DOI: https://doi.org/10.1038/emm.2007.23

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • checkpoint kinase 1
  • checkpointkinase 2
  • DNA damage
  • phosphorylation
  • substrate specificity

This article is cited by

  • GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage

    • Lauren A. Callender
    • Johannes Schroth
    • Sian M. Henson

    Nature Communications (2021)

  • UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target

    • Kumar Saurabh
    • Parag P. Shah
    • Levi J. Beverly

    BMC Cancer (2020)

  • Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

    • Yingmei Wang
    • Ping Ji
    • Wei Zhang

    Molecular Cancer (2009)

  • Akt2, but not Akt1, is required for cell survival by inhibiting activation of JNK and p38 after UV irradiation

    • M-A Kim
    • H-J Kim
    • J Yun

    Oncogene (2009)

  • The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

    • Xiang-Jiao Yang
    • Edward Seto

    Nature Reviews Molecular Cell Biology (2008)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited